Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance
Cardlytics reported Q2 2026 revenue of $36.9 million, down 36% year-over-year, with adjusted EBITDA of $1.7 million. Management stated results were within guidance and highlighted monthly margin improvements, though net loss widened to $14.9 million and cash balance decreased to $28.0 million.
Key figures
- Revenue
- 36882000
- Guidance
- Q3 2026 Revenue $34.0M-$39.0M, Billings $61.0M-$67.0M, Adj EBITDA $0-$3.0M
- Mqu
- 185400000
- Acpu
- 0.11
- Billings
- 65500000
- Adjusted ebitda
- 1700000
- Adjusted contribution
- 21300000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.